Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Atara Biotherapeutics, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Atara Biotherapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q1 2019 to Q3 2025.
  • Atara Biotherapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2025 was $6.32M.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Atara Biotherapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.32M Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $6.74M Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $9.99M Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $11.2M -$6.39M -36.4% Dec 31, 2024 10-K 2025-03-07
Q4 2023 $17.5M -$4.62M -20.8% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $22.2M +$7.58M +52% Dec 31, 2022 10-K 2023-02-08
Q3 2022 $23.9M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $25.8M Jun 30, 2022 10-Q 2022-08-08
Q4 2021 $14.6M +$6.17M +73.3% Dec 31, 2021 10-K 2022-02-28
Q4 2020 $8.42M -$1.52M -15.3% Dec 31, 2020 10-K 2021-03-01
Q4 2019 $9.93M Dec 31, 2019 10-K 2020-02-27
Q3 2019 $10.3M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $10.7M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $10.9M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.